We sat down and spoke with industry expert Andre Ulloa, Partner and Executive Advisor of M&A Healthcare Advisors, to discuss the key considerations investors should know before investing in the health clinic market. Ulloa sheds light on the factors driving...
The ear, nose and throat (ENT) market, also known as otolaryngology, encompasses a wide range of services. For our purposes, we categorize all ENT and allergy-related services under the ENT subsector. This classification is based on the comprehensive expertise of...
Historically, nephrology has not seen a large amount of investment activity. In the past few years, there have only been a handful of transactions. According to data captured in the LevinPro HC database, in 2021 there were only five transactions. In 2022, there...
The deal activity of Home Health & Hospice investors has been on a steady decline over the past two years, ever since reaching its peak in the fourth quarter of 2021. There were 95 reported transactions in the 2023 Home Health & Hospice market, which is a 16%...
Market conditions that include rising borrowing costs and increasing construction-related expenses have led those engaged in behavioral healthcare M&A deals to employ various growth and expansion strategies. Shane Harmon, senior director, behavioral health...
Last week, the LevinPro HC team attended The Healthcare Services Investment Conference hosted by DealFlow Events. It was held just outside Times Square in New York City and featured a wide variety of healthcare industry members, from sell-side advisors to healthcare...